Bullous Pemphigoid with Atypical Skin Lesions and Acute Interstitial Nephritis: A Case Report and Focused Literature Review
| Autor: | Alaap Mehta, Anjali Shinde, Gary Barsky, Nadew Sebro, Bindu Ganapathineedi, Susmitha Dande |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Male
Pemphigoid medicine.medical_specialty Drug-Related Side Effects and Adverse Reactions 030204 cardiovascular system & hematology Diagnosis Differential 03 medical and health sciences 0302 clinical medicine Hypereosinophilic Syndrome Pemphigoid Bullous medicine Humans Eosinophilia Erythema multiforme Aged Erythema Multiforme Cephalexin integumentary system medicine.diagnostic_test Hypereosinophilic syndrome business.industry Articles General Medicine medicine.disease Eosinophiluria Dermatology Anti-Bacterial Agents Drug Hypersensitivity Syndrome 030220 oncology & carcinogenesis Skin biopsy Nephritis Interstitial Bullous pemphigoid medicine.symptom business |
| Zdroj: | The American Journal of Case Reports |
| ISSN: | 1941-5923 |
| DOI: | 10.12659/ajcr.911422 |
| Popis: | Patient: Male, 76 Final Diagnosis: Drug induced bullous pemphigoid Symptoms: Skin rash Medication: Cephalexin Clinical Procedure: Skin biopsy Specialty: General and Internal Medicine Objective: Unusual clinical course Background: The hallmark of bullous pemphigoid (BP) is widespread tense blisters arising on normal or erythematous skin, often with marked pruritus, the diagnosis of which is confirmed by direct immunofluorescence (DIF). BP is an autoimmune process that can be induced, though rarely, by medications. Drug-induced BP often has atypical clinical presentation, which requires a good understanding of other dermatological conditions with similar presentations, in particular, bullous subtype of erythema multiforme. End organ involvement warrants differentiating it from one of the severe cutaneous adverse reaction (SCAR) syndromes. Case Report: A 76-year-old African American male presented with extensive targetoid purplish skin lesions that clinically resembled atypical erythema multiforme, and one tense blister that raised a concern for BP. The patient presented 6 weeks after treatment with cephalexin for a urinary tract infection. Initial workup showed serum eosinophilia, acute kidney injury and eosinophiluria requiring deliberations on SCAR syndromes. A skin biopsy at an intralesional location showed a negative DIF, however, a skin biopsy at a perilesional site showed a positive DIF, confirming the diagnosis of BP. Conclusions: This case demonstrates an atypical presentation of BP induced by drugs. It emphasizes the need for a greater level of awareness of diagnosis and treatment of the various entities that fall under adverse drug reactions in the elderly. It also highlights the need for appropriate choice of skin biopsy techniques (intralesional versus perilesional) to avoid misdiagnosis, as well as lessons on how to approach dermatologic conditions with end organ involvement for hospitalists and other medical professionals who routinely deal with undifferentiated disease conditions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|